Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BD3G
|
|||
| Former ID |
DNC007755
|
|||
| Drug Name |
4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine
|
|||
| Synonyms |
CHEMBL391379; Morpholine, 4-[[5-bromo-2-[(4-chlorophenyl)methoxy]phenyl]methyl]-; 851546-84-4; 4-(2-(4-chlorobenzyloxy)-5-bromobenzyl)morpholine; SCHEMBL5699765; CTK3C9230; DTXSID80458181; 4-[[5-bromo-2-[(4-chlorophenyl)methoxy]phenyl]methyl]morpholine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H19BrClNO2
|
|||
| Canonical SMILES |
C1COCCN1CC2=C(C=CC(=C2)Br)OCC3=CC=C(C=C3)Cl
|
|||
| InChI |
1S/C18H19BrClNO2/c19-16-3-6-18(23-13-14-1-4-17(20)5-2-14)15(11-16)12-21-7-9-22-10-8-21/h1-6,11H,7-10,12-13H2
|
|||
| InChIKey |
JUKUHNUKMFGLIK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 851546-84-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | C-C chemokine receptor type 5 (CCR5) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Chemokine signaling pathway | ||||
| Endocytosis | ||||
| Toxoplasmosis | ||||
| Viral carcinogenesis | ||||
| NetPath Pathway | TSLP Signaling Pathway | |||
| TCR Signaling Pathway | ||||
| IL2 Signaling Pathway | ||||
| Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
| Pathway Interaction Database | IL12-mediated signaling events | |||
| Reactome | Binding and entry of HIV virion | |||
| Chemokine receptors bind chemokines | ||||
| G alpha (i) signalling events | ||||
| WikiPathways | TCR Signaling Pathway | |||
| GPCRs, Class A Rhodopsin-like | ||||
| HIV Life Cycle | ||||
| Peptide GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| GPCRs, Other | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivatives. Bioorg Med Chem Lett. 2007 Jan 1;17(1):231-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.